Healthy Living: Pancreatic Cancer Research
Pancreatic cancer kills 95 percent of the people diagnosed with it.
Chemotherapy helps, but only extends survival for a few months.
A U.S. patent is pending on the gene delivery technology developed by Bruno Doiron.
Obesity and diabetes are major risk factors for pancreatic cancer. Researchers say the new technology can be used to examine this link.